RBI 5000
Alternative Names: COVID-19 vaccine- Immunomic Therapeutics/Replicate Bioscience; RBI-5000Latest Information Update: 29 Jul 2024
Price :
$50 *
At a glance
- Originator Immunomic Therapeutics; Replicate Bioscience
- Class RNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Epstein-Barr virus infections
- Discontinued COVID 2019 infections
Most Recent Events
- 29 Jul 2024 Discontinued for COVID-2019 infections in USA (Parenteral) (Replicate Biosciences pipeline, July 2024)
- 29 Jul 2024 Preclinical trials in Epstein-Barr virus infections (Prevention) in USA (Parenteral) (Replicate Biosciences pipeline, July 2024)
- 28 Jul 2024 No recent reports of development identified for research development in COVID-2019-infections in USA (Parenteral)